Nascent Biotech Board of Directors

Sean Carrick

President

As President, Sean Carrick brings to Nascent an extensive track record of success with a career that spans more than 25 years of building and leading successful medical device companies in large, mid-cap and venture-backed stages. Previously, Mr. Carrick served as Director of Southern US Sales at Maquet Medical Systems, where he was responsible for sales and sales operations in the Southern US and Caribbean. Prior to Maquet Mr. Carrick served as Florida Director of Sales at the Linvatec Division of Conmed Corporation. In addition to extensive marketing and sales experience, Mr. Carrick served as President of Silver Star Mining Corporation. There he was responsible for all business management and strategic direction. Mr. Carrick holds a BS Degree in Economics and Business Administration from Duquesne University and strategic leadership and management certificates from the Cogency Group, Eckerd College and Maquet.

Brandon J. Price, PhD

Senior Vice President, Business Development

Dr. Price has more than 30 years in the biopharmaceutical industry. Recently he co-founded Biogenin, a Mexican company that licenses, develops and registers human and veterinary products (pharmaceuticals, diagnostics and medical devices) for Latin American markets. Dr. Price has been CEO of four biotechnology start-ups (plant transgenic expression systems, stem cell therapies, chemical cancer drugs, synthetic vaccines), and has held senior management positions at Cardinal Health and Ortho Diagnostic Systems (a Johnson & Johnson company). In addition, he co-founded the Institute for Cell Analysis at the University of Miami (FL), and the International Center for Entrepreneurial Excellence at the University of Guadalajara. He has served as Board Chair of the Virginia Biotechnology Association, Maryland’s counterpart, MdBIO, and was named 2001 Biotechnology Leader of the Year in Virginia. He currently sits on the Boards of four companies, and chairs the Advisory Board for the Professional Science Management Program in Bioinformatics at Virginia Commonwealth University (Richmond, VA). Presently, he is Visiting Professor at the University of Guadalajara School of Business where he teaches the course “Entrepreneurism and Business Planning”. He holds the B.S. and Ph.D. degrees in Biophysics from the University of Michigan in Ann Arbor and is the author of more than 50 articles in the scientific and business literature.

Lowell Holden

Chief Financial Officer

Lowell Holden has been the CFO and Chief Accounting Officer of the Company since May 2014.  Since 1983, Mr. Holden has owned and operated his own consulting firm, LS Enterprises, Inc., which provides business consulting, accounting and other services to businesses.  Mr. Holden has a broad range of business experience including managing, securing financing, structuring of transactions, and is experienced and knowledgeable in managing relationships with customers, financing institutions and stockholders. Mr. Holden also has a background in assisting companies in fulfilling their financial auditing and SEC reporting requirements. Mr. Lowell Holden has a Bachelor’s of Science degree from Iowa State University.